MedTrace Logo

Assessment of the Immunization Levels Against Sars-Cov2 Virus in Subjects Who Have Received EU-approved COVID-19 Vaccines

NCT04954651 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2022-06-06

No results posted yet for this study

Summary

Patients who voluntarily visit vaccination centers in Greece against COVID-19 are recruited and their immunization levels against Sars-Cov2 are assesed by measurement of the levels of serum antibodies against Sars-cov-2 before vaccination and in time intervals up to 6-9 months post-vaccination (indicatively 0-1-3-6-9 months post-vaccination).

Conditions

  • SARS-CoV2 Infection
  • Vaccine Reaction

Interventions

BIOLOGICAL

Approved vaccines against Sars-Cov2

Subjects who voluntarily are vaccinated against Sars-Cov-2 with any of the approved vaccines by EU

Sponsors & Collaborators

  • University of Patras

    lead OTHER

Principal Investigators

  • Ioannis Habeos, MD, PhD · University of Patras

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-07
Primary Completion
2022-03-28
Completion
2022-03-28

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04954651 on ClinicalTrials.gov